|
Hematology/Oncology Grand Rounds: Acute Leukemia in Pregnancy Immune-checkpoint inhibition in gastro-esophageal carcinoma: a closer look at the emerging evidence |
12/21/2020 - 12:00pm to 1:00pm |
|
Cure is the goal but not the whole story: Improving the leukemia treatment and survival journey for AYAs |
12/14/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds: Measurable residual disease in acute myeloid leukemia: where do we stand? |
11/30/2020 - 12:00pm to 1:00pm |
|
When MPNs start blasting off: genomics of progression and treatment approaches |
11/23/2020 - 12:00pm to 1:00pm |
|
From Interventional Pharmacoeconomics to Ambiguity |
11/16/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds: Why do Oncologists Deceive their Patients? |
11/09/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds: Metabolism, Diet and Cancer |
11/02/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds: Autoimmunity and GVHD after Hematopoietic Stem Cell Transplant & A tale of two sides: advances in the management of thrombotic microangiopathies |
10/26/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds-Shubitz Lecture:“Beliefs and Realities of Cancer Drug Development: 1980-2020” |
10/19/2020 - 12:00pm to 1:00pm |
|
Hematology/Oncology Grand Rounds: Patient-Reported Outcomes in CLL/SLL Patients Receiving Novel Oral Agents and Ipi/Nivo vs. Immunotherapy/VEGFR Inhibitors in Advanced RCC |
10/12/2020 - 12:00pm to 1:00pm |
Facebook
X
LinkedIn
Forward